Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease A Kodimuthali, SSL Jabaris, M Pal Journal of medicinal chemistry 51 (18), 5471-5489, 2008 | 178 | 2008 |
Preparation and evaluation of mesalamine collagen in situ rectal gel: A novel therapeutic approach for treating ulcerative colitis SK Ramadass, S Perumal, SL Jabaris, B Madhan European journal of pharmaceutical sciences 48 (1-2), 104-110, 2013 | 54 | 2013 |
Tumor targeting using polyamidoamine dendrimer–cisplatin nanoparticles functionalized with diglycolamic acid and herceptin A Kesavan, P Ilaiyaraja, WS Beaula, VV Kumari, JS Lal, C Arunkumar, ... European Journal of Pharmaceutics and Biopharmaceutics 96, 255-263, 2015 | 53 | 2015 |
Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats SGSL Jabaris, H Sumathy, RS Kumar, S Narayanan, S Thanikachalam, ... European Journal of Pharmacology 746, 138-147, 2015 | 49 | 2015 |
Is Mucormycosis an inevitable complication of Covid-19in India? R Bhogireddy, V Krishnamurthy, S Sugin Lal Jabaris, CP Pullaiah, ... The Brazilian Journal of Infectious Diseases 25 (3), 101597, 2021 | 48 | 2021 |
The current situation of COVID-19 in India SSL Jabaris, V Ananthalakshmi Brain, Behavior, & Immunity-Health 11, 100200, 2021 | 40* | 2021 |
Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system SSL Jabaris, H Sumathy, R Girish, S Narayanan, M Sugumar, CS Babu, ... Brain research 1622, 279-291, 2015 | 35 | 2015 |
Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain R Nirogi, P Jayarajan, R Abraham, D Shanmuganathan, MA Rasheed, ... European journal of pharmacology 668 (1-2), 155-162, 2011 | 32 | 2011 |
Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: A new treatment strategy SK Ramadass, SL Jabaris, RK Perumal, VI HairulIslam, A Gopinath, ... European Journal of Pharmaceutical Sciences 91, 216-224, 2016 | 27 | 2016 |
Neuropharmacological evaluation of Morinda citrifolia Linn fruits extract in animal models of obsessive-compulsive disorder S Jeyabalan, L Bala, K Subramanian, SL Jabaris, M Sekar, LS Wong, ... Frontiers in Pharmacology 13, 993927, 2022 | 17 | 2022 |
Roflumilast: a potential drug for the treatment of cognitive impairment? LJS Sugin, A Murugesan, M Bindu, KN Sunil Neuroscience Letters 736, 135281, 2020 | 14 | 2020 |
Potential effects of noni (Morinda citrifolia L.) fruits extract against obsessive-compulsive disorder in marble burying and nestlet shredding behavior mice models S Jeyabalan, L Bala, K Subramanian, SL Jabaris, M Sekar, LS Wong, ... Frontiers in Pharmacology 13, 993927, 2022 | 8 | 2022 |
Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19 SSL Jabaris, V Ranju Pulmonary Pharmacology & Therapeutics 66, 101978, 2020 | 8* | 2020 |
Fabrication of novel bio-compatible cefixime nanoparticles using chitosan and Azadirachta indica fruit mucilage as natural polymers HarikaBalya, Arun Radhakrishnan, Sugin LalJabaris, SaiGopal Dvr ... Journal of Drug Delivery Science and Technology 66, 102750, 2021 | 6 | 2021 |
Kabasura Kudineer, a Siddha medicine against COVID-19 infection: scope and future perspective SSL Jabaris, Venkataraman K International Journal of Complementary & Alternative Medicine 14 (3), 173-174, 2021 | 5 | 2021 |
Recent preclinical study offers a promising clue: Role of Regulatory T cells as biomarkers in migraine A Murugesan, SSL Jabaris Immunology Letters 240, 9-11, 2021 | 4 | 2021 |
Molecular Docking Studies of Phytoconstituents Identified in Traditional Siddha Polyherbal Formulations Against Possible Targets of SARS-CoV-2 LK Selvaraj, G Thayumanavan, S Jeyabalan, SL Jabaris Journal of Molecular Docking 1 (1), 15-24, 2021 | 1 | 2021 |
P4-257 SUVN-G1031, A NOVEL SELECTIVE H3 RECEPTOR ANTAGONIST IN ANIMAL MODELS OF COGNITIVE DEFICITS P Jayarajan, D Shanmuganathan, SL Jabaris, MR Babu, K Baburao, ... RECEPTOR 4, 257, 2011 | 1 | 2011 |
COVID-19, its Prevention and Treatment in the light of Ayush Medicines SL Jabaris S, V Krishnamurthy, D Sankaramourthy Pharmacological Research-Natural Products, 100040, 2024 | | 2024 |
POORANA CHANDROTHAYA CHENTHURAM (PCC), A SIDDHA SYSTEM OF MEDICINE PROTECTS AGAINST SCOPOLAMINE‐INDUCED COGNITIVE IMPAIRMENTS IN EXPERIMENTAL RATS SLJS George, CP Pullaiah, B Krishnamoorthy Alzheimer's & Dementia 19, e076085, 2023 | | 2023 |